Literature DB >> 16809290

Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

David Ghez1, Yves Lepelletier, Sophie Lambert, Jean-Marie Fourneau, Vincent Blot, Sébastien Janvier, Bertrand Arnulf, Peter M van Endert, Nikolaus Heveker, Claudine Pique, Olivier Hermine.   

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) is transmitted through a viral synapse and enters target cells via interaction with the glucose transporter GLUT1. Here, we show that Neuropilin-1 (NRP1), the receptor for semaphorin-3A and VEGF-A165 and a member of the immune synapse, is also a physical and functional partner of HTLV-1 envelope (Env) proteins. HTLV-1 Env and NRP1 complexes are formed in cotransfected cells, and endogenous NRP1 contributes to the binding of HTLV-1 Env to target cells. NRP1 overexpression increases HTLV-1 Env-dependent syncytium formation. Moreover, overexpression of NRP1 increases both HTLV-1 and HTLV-2 Env-dependent infection, whereas down-regulation of endogenous NRP1 has the opposite effect. Finally, overexpressed GLUT1, NRP1, and Env form ternary complexes in transfected cells, and endogenous NRP1 and GLUT1 colocalize in membrane junctions formed between uninfected and HTLV-1-infected T cells. These data show that NRP1 is involved in HTLV-1 and HTLV-2 entry, suggesting that the HTLV receptor has a multicomponent nature.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809290      PMCID: PMC1489069          DOI: 10.1128/JVI.02719-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.

Authors:  Nicolas Manel; Felix J Kim; Sandrina Kinet; Naomi Taylor; Marc Sitbon; Jean-Luc Battini
Journal:  Cell       Date:  2003-11-14       Impact factor: 41.582

2.  Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation.

Authors:  Manisha D Nath; Francis W Ruscetti; Cari Petrow-Sadowski; Kathryn S Jones
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

3.  Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN.

Authors:  Cinzia Nobile; Arnaud Moris; Françoise Porrot; Nathalie Sol-Foulon; Olivier Schwartz
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Neuropilin-1 on hematopoietic cells as a source of vascular development.

Authors:  Yoshihiro Yamada; Yuichi Oike; Hisao Ogawa; Yasuhiro Ito; Hajime Fujisawa; Toshio Suda; Nobuyuki Takakura
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

5.  Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.

Authors:  C Pique; C Lagaudrière-Gesbert; L Delamarre; A R Rosenberg; H Conjeaud; M C Dokhélar
Journal:  Virology       Date:  2000-10-25       Impact factor: 3.616

6.  Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.

Authors:  Tadahiko Igakura; Jane C Stinchcombe; Peter K C Goon; Graham P Taylor; Jonathan N Weber; Gillian M Griffiths; Yuetsu Tanaka; Mitsuhiro Osame; Charles R M Bangham
Journal:  Science       Date:  2003-02-13       Impact factor: 47.728

7.  Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.

Authors:  Josefina D Piñon; P J Klasse; Sushma R Jassal; Sandy Welson; Jonathan Weber; David W Brighty; Quentin J Sattentau
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.

Authors:  Vincent Blot; Lélia Delamarre; Fabien Perugi; Danielle Pham; Serge Bénichou; Richard Benarous; Toshihiko Hanada; Athar H Chishti; Marie-Christine Dokhélar; Claudine Pique
Journal:  J Cell Sci       Date:  2004-08-01       Impact factor: 5.285

9.  Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding.

Authors:  Vincent Blot; Fabien Perugi; Bernard Gay; Marie-Christine Prévost; Laurence Briant; Frédéric Tangy; Hugues Abriel; Olivier Staub; Marie-Christine Dokhélar; Claudine Pique
Journal:  J Cell Sci       Date:  2004-05-01       Impact factor: 5.285

Review 10.  DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission.

Authors:  T B H Geijtenbeek; Y van Kooyk
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

View more
  73 in total

Review 1.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

2.  Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion.

Authors:  Priya Kannian; Han Yin; Rami Doueiri; Michael D Lairmore; Soledad Fernandez; Patrick L Green
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin.

Authors:  Matthew W Parker; Lance M Hellman; Ping Xu; Michael G Fried; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

4.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

5.  Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors.

Authors:  Dmitriy Mazurov; Anna Ilinskaya; Gisela Heidecker; Patricia Lloyd; David Derse
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

6.  Necroptosis-based CRISPR knockout screen reveals Neuropilin-1 as a critical host factor for early stages of murine cytomegalovirus infection.

Authors:  Rebecca K Lane; Hongyan Guo; Amanda D Fisher; Jonathan Diep; Zhao Lai; Yidong Chen; Jason W Upton; Jan Carette; Edward S Mocarski; William J Kaiser
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

7.  Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.

Authors:  Daniela Romer; David W Brighty; Cynthia L Robson; Quentin J Sattentau
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

8.  HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.

Authors:  Sophie Lambert; Manuella Bouttier; Roger Vassy; Michel Seigneuret; Cari Petrow-Sadowski; Sébastien Janvier; Nikolaus Heveker; Francis W Ruscetti; Gérard Perret; Kathryn S Jones; Claudine Pique
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

9.  The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Authors:  Kathryn S Jones; Ying K Huang; Sébastien A Chevalier; Philippe V Afonso; Cari Petrow-Sadowski; Daniel C Bertolette; Antoine Gessain; Francis W Ruscetti; Renaud Mahieux
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

10.  DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.

Authors:  Pooja Jain; Sharrón L Manuel; Zafar K Khan; Jaya Ahuja; Kevin Quann; Brian Wigdahl
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.